Newsletter Subject

3 Pot Stocks that Could Rally after the Election

From

energyandcapital.com

Email Address

newsletter@energyandcapital.com

Sent On

Fri, Sep 13, 2024 03:32 PM

Email Preheader Text

The first thing you have to consider is... showing that, as of August 2024, only about 27% of U.S. c

The first thing you have to consider is... [Energy and Capital Header] Practical Investment Analysis for the New Energy Economy 3 Pot Stocks that Could Rally after the Election Jeff Siegel | Sep 13, 2024 Are cannabis stocks ready to rally? [cannabis stocks] Those who are enthusiastic about both Donald Trump and Kamala Harris supporting legalization in some form would say yes. But it’s going to take a lot more than just lip service from the two major candidates. You see, when asking yourself, are cannabis stocks ready to rally, the first thing you have to consider is the overall health of the cannabis market altogether. It didn’t get much coverage in the mainstream press, but last month, [Whitney Economics released a report]( showing that, as of August 2024, only about 27% of U.S. cannabis businesses were profitable, with about 72% identified as either just breaking even or completely unprofitable. To put this in perspective, the U.S. Chamber of Commerce says that 65.3% of all small businesses are profitable. So the cannabis industry is well below the national average. Which is bizarre when you consider that one of the easiest things in the world to sell is weed. But not in the “legal” market. Could This Tiny AI Stock Set off “the Mother of All Melt-Ups”!?!? “This Is the Penny Stock Trade of the Year” [TRADE ALERT ENCLOSED: CLICK HERE for the SHORT 5-MINUTE VIDEO...]( To be fair, the reason most of these companies are not profitable is because of overzealous taxation. Some cannabis businesses pay tax rates as high as 52.5%. Imagine running a business, and more than half of your revenues were stolen every year. It’s absurd. I can’t imagine any business owner wanting to operate in such a financially hostile environment. That being said, the tide is turning in Washington when it comes to legalization. And while we won’t see full-scale legalization anytime soon, those eager to progress on cannabis policy are pushing to move cannabis from a Schedule 1 drug to a Schedule 3 drug. The Biden administration [formerly proposed this move]( a few months ago, and both Trump and Harris seem to support it. This wouldn’t make cannabis possession legal, but it would allow for one big change that would make some of these cannabis stocks very attractive. You see, under the Schedule 1 classification, cannabis companies pay taxes on their gross income instead of their net income. They can’t take the typical deductions any other company can. And this is one of the reasons margins are so razor thin in the cannabis industry. But if these companies can finally start utilizing the same deductions other companies take, you’re going to see the valuation of some of these cannabis stocks soar. The question is, will rescheduling really happen? And if so, when? Uranium Is Surging: Where to Invest Now The price for uranium is skyrocketing. It hasn’t been this high in more than 16 years. Utilities are scrambling to secure as much fuel as they possibly can. As the American Nuclear Society puts it, "[The U.S. is] on the verge of a crisis." The last time we were in a uranium supply crunch, investors could’ve pocketed gains as huge as 8,200%. One little-known company from the Midwest is in the perfect position to ride this new bull run to stunning highs. Alex Koyfman just published an urgent presentation on this unique opportunity. Access is instant and free. [Get the full story here while there’s still time.]( Are Cannabis Stocks Ready to Rally? We’ll soon find out! When it comes to politics and policy, I believe nothing until it actually happens. This is especially true in today’s political climate where these people will literally say anything to get your vote. Even if it’s a complete lie. And while I do believe rescheduling will come before 2026, the process itself may be too slow to save some of these fledgling cannabis companies. Still, if you think cannabis stocks are ready to rally, I would recommend owning only the ones that have been able to generate significant revenue and minimize losses while still under the Schedule 1 status. These include... - Innovative Industrial Properties (NYSE: IIPR) — Market Cap: $3.54 Billion - Green Thumb Industries: (OTCBB: GTBIF) — Market Cap: $2.45 Billion - Curaleaf (OTCBB: CURLF) — Market Cap: $2.1 Billion At this point, it’s really just a waiting game. And while I do believe cannabis stock will rally on rescheduling, I’m not convinced they’ll rally enough to make the wait worthwhile. Especially when there are real opportunities right now that are delivering the kinds of gains that’ll dwarf anything coming out of the cannabis sector. Take [this new bitcoin loophole strategy]( that’s already allowed us to score gains in excess of 6,700%. If you’re unfamiliar, this bitcoin loophole strategy, discovered by bitcoin export Brian Hicks, allows you to tap into the meteoric growth of bitcoin without actually having to own any of it. Based on recent returns, this is the kind of thing that can turn $5,000 into more than $348,200. And if you don’t believe it, just [look at the evidence for yourself.]( Or better yet, just [download Brian’s latest investment note on this bitcoin loophole strategy](. Not only will it show you exactly how it works, but it even gives you detailed instructions on how you can [get a piece of this action for yourself — right now.]( To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]Check us out on YouTube!]( Jeff is the founder and managing editor of Green Chip Stocks. For more on Jeff, go to his editor's [page](. Want to hear more from Jeff? [Sign up to receive emails directly from him]( ranging from market commentaries to opportunities that he has his eye on. [EAC ICYMI Header]( Biotech Firm Gets MAJOR FDA Approval(Buy This $5 Stock) Biotech firm Embecta has just received FDA clearance for its disposable insulin patch pump. This could mark a critical step forward in diabetes care. But we’re not buying Embecta. Instead, there’s another imminent FDA decision involving a small $5 biotech firm. We believe there’s a HUGE potential for profit for anyone who acts quickly. That’s why we’re rushing you this message. Please note, this is extremely time-sensitive. Getting ahead of this early could lead to some serious money. [Everything is revealed right here.]( [Fb]( [Li]( [Tw]( This email was sent to {EMAIL}. You can manage your subscription and get our privacy policy [here](. Energy and Capital, Copyright © 3 East Read Street, Baltimore, MD 21202. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info [here]( including our privacy policy and information on how to manage your subscription. If you are interested in our other publications, please call our customer service team at [1-877-303-4529](tel:/18773034529).

Marketing emails from energyandcapital.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

04/12/2024

Sent On

04/12/2024

Sent On

02/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.